Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tamara A. Sussman, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sheng IY, Gupta S, Reddy CA, Angelini D, Funchain P, Sussman TA, Sleiman J, Ornstein MC, McCrae K, Khorana AA. Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors. Target Oncol. 2022 09; 17(5):563-569. PMID: 35986816.
    Citations:    Fields:    Translation:Humans
  2. Sussman TA, Knackstedt R, Wei W, Funchain P, Gastman BR. Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016. J Immunother Cancer. 2022 08; 10(8). PMID: 35998982; PMCID: PMC9403163.
    Citations:    Fields:    Translation:Humans
  3. Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley CJ, Owen DH, Abou Alaiwi S, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman TA, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Dal Bello MG, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Choueiri TK, Johnson DB, Marron TU, Wang Y, Naqash AR. Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. JAMA Oncol. 2021 Dec 01; 7(12):1856-1861. PMID: 34734989; PMCID: PMC8569601.
    Citations: 4     Fields:    Translation:Humans
  4. Sheng IY, Gupta S, Reddy CA, Angelini D, Funchain P, Sussman TA, Sleiman J, Ornstein MC, McCrae K, Khorana AA. Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy. Target Oncol. 2021 11; 16(6):813-821. PMID: 34741719.
    Citations: 1     Fields:    Translation:Humans
  5. Speaker SL, Rastogi R, Sussman TA, Hu B, Misra-Hebert AD, Rothberg MB. Treatment of Patients with Prediabetes in a Primary Care Setting 2011-2018: an Observational Study. J Gen Intern Med. 2021 04; 36(4):923-929. PMID: 33449282; PMCID: PMC8041989.
    Citations: 2     Fields:    Translation:Humans
  6. Sussman TA, Li H, Hobbs B, Funchain P, McCrae KR, Khorana AA. Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival. J Immunother Cancer. 2021 01; 9(1). PMID: 33436486; PMCID: PMC7805375.
    Citations: 15     Fields:    Translation:Humans
  7. Sussman TA, Funchain P, Singh A. Clinical Trials in Metastatic Uveal Melanoma: Current Status. Ocul Oncol Pathol. 2020 Dec; 6(6):381-387. PMID: 33447587; PMCID: PMC7772871.
    Citations: 6     
  8. Conic RRZ, Knackstedt R, Sussman TA, Rambhia S, Damiani G, Funchain P, Ko J, Gastman BR. Utilization and impact of immunotherapy in stage IV melanoma using the National Cancer Database. Melanoma Res. 2020 08; 30(4):376-385. PMID: 32404731.
    Citations: 2     Fields:    Translation:Humans
  9. Sussman TA, Abazeed ME, McCrae KR, Khorana AA. RNA expression and risk of venous thromboembolism in lung cancer. Res Pract Thromb Haemost. 2020 Jan; 4(1):117-123. PMID: 31989093; PMCID: PMC6971308.
    Citations: 1     
  10. Knackstedt R, Sussman TA, McCahon L, Song JM, Funchain P, Gastman B. Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases. Ann Oncol. 2019 08 01; 30(8):1399-1400. PMID: 31250007.
    Citations: 5     Fields:    Translation:HumansCells
  11. Sussman TA, Kruse ML, Thacker HL, Abraham J. Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy. J Oncol Pract. 2019 07; 15(7):363-370. PMID: 31291563.
    Citations: 3     Fields:    Translation:Humans
  12. Sussman TA, Shrestha NK, Miklowski M. Eyes of the mimicker. Cleve Clin J Med. 2018 May; 85(5):356-357. PMID: 29733787.
    Citations:    Fields:    Translation:HumansCells
  13. Sussman TA, Khunger M, Velcheti V. A case of crizotinib-induced esophageal ulcers. Lung Cancer Manag. 2017 Jul; 6(1):5-7. PMID: 30643564; PMCID: PMC6310301.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sussman's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (58)
Co-Authors (5)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.